Grünenthal's commitments

As a research-based pharmaceutical company, Grünenthal recognizes the importance of publicly registering clinical trials and making information including results available.

To help trial participants, healthcare professionals and researchers to easily find information on Grünenthal sponsored clinical trials in patients, Grünenthal has committed:


  • To register clinical trials on freely accessible internet registries, e.g.,
  • To disclose clinical trial information (including results) on freely accessible internet registries, e.g.,
  • Meet the EFPIA Principles for Responsible Clinical Trial Data Sharing.
    • Enhance data sharing with researchers.
    • Enhance public access to clinical trial information.
    • Share results with patients who participate in clinical trials.
    • Certify procedures for sharing clinical trial information.
    • Commitment to publish clinical trial results.
  • Protect subject privacy when disclosing or sharing clinical trial information.

See the policy statement Meeting the EFPIA Principles for Responsible Clinical Trial Data Sharing, to see how Grünenthal is meeting these commitments.

Responsible Clinical Trial Data Sharing

Grünenthal began implementation of the Principles for Responsible Clinical Trial Data Sharing issued in January 2014 by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA).

Grünenthal welcomes requests from suitably qualified scientific and medical researchers for access to patient- and trial-level data from clinical trials as necessary for conducting legitimate research.

Grünenthal Clinical Trial Portal

The Grünenthal Clinical Trial Portal gives access to information on interventional clinical trials in patients by active ingredient and access to information on Clinical Data Sharing with Researchers.

Ongoing clinical trials listed here have been linked to information posted on publically accessible registries,, the European Union Clinical Trials Register, or the German Institute of Medical Documentation and Information (Deutsches Institut für Medizinische Dokumentation und Information [DIMDI]) and PharmNet.Bund.


Please read the below important information before accessing Grünenthal clinical trial Information.

Please note that this portal does not propose to offer you therapeutic assistance or therapeutic suggestions, nor should this keep you from seeking your doctor´s advice before making any decisions on your treatment.

Healthcare professionals should not view this portal as a prescription consultation service. Please rather refer to the official prescription information which is approved and available in your country.

Grünenthal has compiled the contents of this portal with utmost care. However, the information given here may differ with data published elsewhere. This may, for example, occur due to the limited scope of this portal. In case of doubt, please refer to the prescription information which is approved in your country.

Please note that there are registries that extract information from various sources. Grünenthal cannot guarantee that these registries are properly maintained and disclaims any liability for information thus collected.

Please note that our General Terms and Conditions as well as our Privacy Statement do also apply on the Grünenthal Clinical Trial Portal.

External Link:
You are now leaving the Grünenthal (IE) website. You will be re-directed to an external website. Grünenthal Pharma Ltd., Ireland accepts no responsibility for the content of other websites. ... Cancel ... Ok